{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:42:41Z","timestamp":1793382161542,"version":"4.5.0"},"reference-count":33,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.1080\/17512433.2025.2544038","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T11:54:02Z","timestamp":1754135642000},"page":"519-530","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Prescribing pattern of disease-modifying antirheumatic drugs in Scotland (2019\u20132023): a population-based retrospective cohort study"],"prefix":"10.1080","volume":"18","author":[{"given":"Amanj","family":"Kurdi","sequence":"first","affiliation":[{"name":"Public Health Scotland, Pharmacy, Glasgow","place":["Scotland, UK"]},{"name":"University of Strathclyde","place":["Glasgow, UK"]},{"name":"Hawler Medical University","place":["Erbil, Iraq"]},{"name":"Al-Kitab University","place":["Kirkuk, Iraq"]},{"name":"Sefako Makgatho Health Sciences University","place":["Pretoria, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euan","family":"Proud","sequence":"additional","affiliation":[{"name":"Public Health Scotland, Pharmacy, Glasgow","place":["Scotland, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stobo","sequence":"additional","affiliation":[{"name":"Public Health Scotland, Pharmacy, Glasgow","place":["Scotland, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morven","family":"Millar","sequence":"additional","affiliation":[{"name":"Public Health Scotland, Pharmacy, Glasgow","place":["Scotland, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Clayton","sequence":"additional","affiliation":[{"name":"Public Health Scotland, Pharmacy, Glasgow","place":["Scotland, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"McTaggart","sequence":"additional","affiliation":[{"name":"Public Health Scotland, Pharmacy, Glasgow","place":["Scotland, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Mueller","sequence":"additional","affiliation":[{"name":"Public Health Scotland, Pharmacy, Glasgow","place":["Scotland, UK"]},{"name":"University of Strathclyde","place":["Glasgow, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Bennie","sequence":"additional","affiliation":[{"name":"Public Health Scotland, Pharmacy, Glasgow","place":["Scotland, UK"]},{"name":"University of Strathclyde","place":["Glasgow, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204627"},{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062183"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1318-y"},{"key":"e_1_3_8_5_1","volume-title":"The state of musculoskeletal Health 2024","author":"Versus Arthritis","year":"2024","unstructured":"Versus Arthritis. The state of musculoskeletal Health 2024. London: Versus Arthritis; 2024."},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab714"},{"key":"e_1_3_8_7_1","volume-title":"Diagnosis and management of psoriasis and psoriatic arthritis in adults: a national clinical guideline","author":"Scottish Intercollegiate Guidelines Network","year":"2010","unstructured":"Scottish Intercollegiate Guidelines Network. Diagnosis and management of psoriasis and psoriatic arthritis in adults: a national clinical guideline. Edinburgh: SIGN; 2010."},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41752"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608345"},{"key":"e_1_3_8_11_1","doi-asserted-by":"crossref","unstructured":"Wang F Sun L and Wang S et al. Efficacy and safety of tofacitinib baricitinib and upadacitinib for rheumatoid arthritis: a systematic review and meta-analysis. Mayo Clinic Proceedings. 2020;95(7):1404\u20131419.","DOI":"10.1016\/j.mayocp.2020.01.039"},{"key":"e_1_3_8_12_1","unstructured":"Hannan BK. Independent review of medicines homecare in Scotland. Scottish government. 2025."},{"key":"e_1_3_8_13_1","unstructured":"National Homecare Medicines Committee (NHMC) Department of Health. Homecare medicines: towards a vision for the future. 2011. (UK)."},{"key":"e_1_3_8_14_1","unstructured":"Public Health Scotland. Home care medicines (HCM) data. 2025. Available from: https:\/\/publichealthscotland.scot\/resources-and-tools\/health-intelligence-and-data-management\/national-data-catalogue\/national-datasets\/search-the-datasets\/home-care-medicines-hcm-data\/"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94504-x"},{"issue":"5","key":"e_1_3_8_16_1","first-page":"S141","article-title":"Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry","volume":"32","author":"Hetland ML","year":"2014","unstructured":"Hetland ML, Jensen DV, Krogh NS. Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry. Clin Exp Rheumatol. 2014;32(5 Suppl 85):S141\u2013S146.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11621"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac048"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1494283"},{"key":"e_1_3_8_20_1","unstructured":"Scottish Government. Scottish index of multiple deprivation 2020. 2020. Available from: https:\/\/www.gov.scot\/collections\/scottish-index-of-multiple-deprivation-2020\/"},{"key":"e_1_3_8_21_1","unstructured":"World Health Organization. International statistical classification of diseases and related health problems: 10th revision (ICD-10). 2019."},{"key":"e_1_3_8_22_1","unstructured":"Statacorp. Stata statistical software: release 13. 2013. College Station (TX)."},{"key":"e_1_3_8_23_1","unstructured":"R Developement Core Team. R: a language and environment for statistical computing (version 4.1.2) 2021. Available from: https:\/\/www.r-project.org\/"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216653"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134527"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14111105"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab245"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215934"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-023-00591-9"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.36469\/jheor.2023.85088"},{"key":"e_1_3_8_31_1","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of early rheumatoid arthritis. Edinburgh. 2011."},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-204"},{"key":"e_1_3_8_33_1","unstructured":"European Medicines Agency. EMA pharmacovigilance risk assessment committee (PRAC). Signal on JAK inhibitors. 2023. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/janus-kinase-inhibitors-jaki#:~:text=EMA%20concluded%20that%20the%20identified other%20than%20those%20listed%20above"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223850"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2025.2544038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T07:05:07Z","timestamp":1755068707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2025.2544038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,3]]}},"alternative-id":["10.1080\/17512433.2025.2544038"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2025.2544038","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}